Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing
Therapeutic Advances in Cardiovascular Disease · 2024
DOI: 10.1177/17539447241233168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2024. Verfasst von Yasusuke Kinoshita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Fukuyama Cardiovascular Hospital, Fukuyama, Japan. Hauptthemen laut MEDLINE: Coronary Vasospasm, Angina Pectoris, Variant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Although guidelines recommend intracoronary acetylcholine (ACh) and ergonovine (ER) provocation testing for diagnosis of vasospastic angina, the feasibility and safety of sequential (combined) use of both pharmacological agents during the same catheterization session remain unclear.
Objectives
In this study, we investigated the feasibility and safety of sequential intracoronary ACh and ER administration for coronary spasm provocation testing.
Methods
The study included 235 patients who showed positive results on ACh and ER provocation testing. Initial intracoronary ACh administration was followed by ER administration for left coronary artery (LCA) spasm provocation testing. Subsequently, the right coronary artery (RCA) was subjected to sequential ACh and ER administration for provocation testing. The primary outcome of the study was the safety of sequential intracoronary ACh and ER provocation testing, which was assessed based on a composite of all-cause death, sustained ventricular tachycardia and fibrillation, and cardiogenic shock.
Results
Even in patients with negative results on sequential intracoronary ACh and ER provocation testing in the LCA and only ACh administration into the RCA, additional administration of ER into the RCA showed a positive provocation test result in 33 of 235 (14.0%) patients; three (1.3%) patients developed adverse effects (cardiogenic shock occurred in all cases) during LCA provocation testing. We observed no deaths attributable to spasm provocation testing.
Conclusion
Sequential administration of intracoronary ACh and ER was associated with a relatively low major complication rate and may be safe and potentially useful for diagnosis of vasospastic angina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Fukuyama Cardiovascular Hospital, Fukuyama, Japan.
- Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan.
ORCID-Profile: Yuichi Saito
Zitieren
APA
Kinoshita, Y., Saito, Y., Kikuta, Y., Sato, K., Taniguchi, M., Goto, K., Takebayashi, H., Haruta, S., & Kobayashi, Y. (2024). Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447241233168
Vancouver
Kinoshita Y, Saito Y, Kikuta Y, Sato K, Taniguchi M, Goto K, et al. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing. Therapeutic Advances in Cardiovascular Disease. 2024. doi:10.1177/17539447241233168
BibTeX
@article{Kinoshita2024,
author = {Kinoshita, Yasusuke and Saito, Yuichi and Kikuta, Yuetsu and Sato, Katsumasa and Taniguchi, Masahito and Goto, Kenji and Takebayashi, Hideo and Haruta, Seiichi and Kobayashi, Yoshio},
title = {Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2024},
doi = {10.1177/17539447241233168}
}
EUVIMED